Displaying 1 to 4 of 4 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Harlem Capital Partners Venture Fund I LP |
2 Dec 2019 | Fund Closing Active |
||
|
NephroGenex Inc NephroGenex is developing a product to slow the progression of diabetic nephropathy. |
United States | N/A |
||
|
|
Pathfinder Therapeutics Inc A medical device company dedicated to increasing the number and effectiveness of surgeries on abdominal and other soft tissue organs. |
United States | N/A |
||
|
|
Protein Discovery Inc Develops solutions for proteomic research, clinical diagnostics, and drug discovery by enabling widespread adoption and application of high throughput |
United States | N/A |